MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,303,950 | -67.5% | 630,395 | -54.4% | 0.00% | -66.7% |
| Q2 2023 | $19,372,608 | 0.0% | 1,382,770 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $19,372,608 | -100.0% | 1,382,770 | -35.8% | 0.01% | -71.0% |
| Q3 2022 | $54,963,564,000 | -21.5% | 2,152,901 | -12.7% | 0.03% | -16.2% |
| Q2 2022 | $70,056,162,000 | -27.4% | 2,465,898 | -9.9% | 0.04% | -9.8% |
| Q1 2022 | $96,477,700,000 | -49.0% | 2,735,404 | -39.4% | 0.04% | -43.1% |
| Q4 2021 | $189,224,593,000 | -6.7% | 4,516,100 | +9.3% | 0.07% | -14.3% |
| Q3 2021 | $202,856,766,000 | +37.4% | 4,133,186 | +16.8% | 0.08% | +33.3% |
| Q2 2021 | $147,671,578,000 | +25.9% | 3,538,739 | +7.6% | 0.06% | +21.2% |
| Q1 2021 | $117,253,569,000 | +11.1% | 3,289,943 | -12.6% | 0.05% | +6.1% |
| Q4 2020 | $105,552,484,000 | – | 3,763,012 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |